Liu2020 Article ClinicalAndBiochemicalIndexesF
Liu2020 Article ClinicalAndBiochemicalIndexesF
Liu2020 Article ClinicalAndBiochemicalIndexesF
Life Sciences
•RESEARCH PAPER• March 2020 Vol.63 No.3: 364–374
https://doi.org/10.1007/s11427-020-1643-8
Received February 5, 2020; accepted February 8, 2020; published online February 9, 2020
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province, and rapidly spread to many
provinces in China as well as other countries. Here we report the epidemiological, clinical, laboratory, and radiological char-
acteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China.
All 12 cases of the 2019-nCoV-infected patients developed pneumonia and half of them developed acute respiratory distress
syndrome (ARDS). The most common laboratory abnormalities were hypoalbuminemia, lymphopenia, decreased percentage of
lymphocytes (LYM) and neutrophils (NEU), elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH), and decreased
CD8 count. The viral load of 2019-nCoV detected from patient respiratory tracts was positively linked to lung disease severity.
ALB, LYM, LYM (%), LDH, NEU (%), and CRP were highly correlated to the acute lung injury. Age, viral load, lung injury
score, and blood biochemistry indexes, albumin (ALB), CRP, LDH, LYM (%), LYM, and NEU (%), may be predictors of disease
severity. Moreover, the Angiotensin II level in the plasma sample from 2019-nCoV infected patients was markedly elevated and
linearly associated to viral load and lung injury. Our results suggest a number of potential diagnosis biomarkers and angiotensin
receptor blocker (ARB) drugs for potential repurposing treatment of 2019-nCoV infection.
2019-nCoV, Angiotensin II, ARDS
Citation: Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al. (2020). Clinical and biochemical indexes from 2019-
nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63, 364–374. https://doi.org/10.1007/s11427-020-1643-8
© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2020 life.scichina.com link.springer.com
Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3 365
Figure 1 A timeline of events in human cases with 2019-nCoV. Patients are ordered in chronological order based on the date of admission to our hospital.
Various milestones in the disease course are indicated with different graphics. Patients within a family were marked in red and blue, respectively.
(Ct) value, which is reciprocal to virus load, with clinical (Figure 3B).
disease severity scores, Acute Physiology and Chronic Among the eight blood biochemistry indexes distinguished
Health Evaluation (APACHE) II Score, partial pressure of in blood samples of 2019-nCoV infected patients, specifi-
arterial oxygen (PaO2)/fraction of inspired oxygen (FiO2) cally ALB, creatinine (CRE), LYM, LYM (%), NEU (%),
ratios, and Murray scores of infected patients (Figure 3A; LDH, CRP, and CD8, we found ALB, LYM, LYM (%), NEU
Figure S3 and Table S1 in Supporting Information). The viral (%), LDH, and CRP were highly linked to lung injury
load of 2019-nCoV detected from patients highly correlated Murray score (Figure 4). Previous studies reported that hy-
with both ARDS index PaO2/FiO2 ratio and lung injury poalbuminemia is a potent, dose-dependent predictor of poor
Murray score, but not with multiple organ dysfunction syn- outcome (Vincent et al., 2003). Therefore, albumin therapy
drome (MODS) score APACHE II (Figure 3A; Figure S3 in might be a potential remedy for NCP.
Supporting Information). This finding is consistent with the We next statistically analyzed the link between the clinical
clinical features in this report that half of the infected patients and biochemical characteristics and disease severity, the
developed ARDS and all patients were diagnosed with definition of which is described in the second edition of
pneumonia, indicating that lung failure of the infected pa- medical guidelines of 2019-nCoV infection from the Na-
tients is the major dysfunction caused by 2019-nCoV in- tional Health Commission of the People’s Republic of China.
fection. Using the Spearman method, we further correlated We calculated the area under the curve (AUC) of the receiver
the Ct value (viral load) of the 2019-nCoV virus with bio- operating characteristics (ROC) curve for characteristics
chemical and clinical indexes, and found that the levels of from 2019-nCoV infected patients. The AUC value of the
infectious diseases indicators albumin (ALB), and percen- ROC curve of age was 1, i.e., age could fully predict the
tage of immunological cells of LYM, and NEU were sig- disease severity of 2019-nCoV infected patients (Figure 5).
nificantly correlated with infected 2019-nCoV viral load The youngest “severe” patient in this Shenzhen cluster aged
Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3 367
a)
Table 1 Epidemiological and clinical features of human subjects hospitalized with 2019-nCoV infection
Characteristics Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 Case 10 Case 11 Case 12
Age 65 66 62 63 63 36 10 35 51 65 72 56
Sex Female Male Male Male Female Male Male Male Male Female Male Female
Onset to admission (days) 9 8 4 5 8 5 5 7 13 16 16 7
Initial symptoms
Fever Yes Yes Yes Yes Yes Yes No Yes No Yes Yes Yes
Cough Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes
Headache No No No No No No No No No No No No
Myalgia Yes Yes No No Yes No No No Yes No No No
Chill Yes Yes Yes No Yes No No No Yes No No No
Nausea or vomiting No Yes No No No Yes No No No No No No
Diarrhea No No Yes No No Yes No No No No No No
Underlying diseases
Chronic heart disease Yes Yes Yes No No No No No No No Yes No
Chronic lung disease No No No Yes No No No No No No No No
Chronic renal disease No No Yes No No No No No No No Yes No
Chronic liver disease No No No No No No No No No No No No
Diabetes No No No No No No No No No Yes No Yes
Hypertension Yes Yes No No No No No No No No Yes No
Cancer No No No No No No No No No No No No
Bacterial co-infections No Yes No Yes No No No No No No No No
Complications
Pneumonia Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
ARDS Yes Yes Yes Yes Yes No No No No Yes No No
Severe ARDS No Yes No Yes No No No No No No No No
Respiratory failure No Yes No Yes No No No No No Yes No No
Hepatic insufficiency No Yes No Yes No No No No No No No No
Renal insufficiency No Yes No Yes No No No No No No No No
Cardiac failure No No No Yes No No No No No No No No
Shock No No No Yes No No No No No No No No
Treatment
Oseltamivir Oseltamivir Oseltamivir Oseltamivir
Antiviral agents Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin Ribavirin
Interferon Interferon Interferon Interferon Interferon Interferon Interferon Interferon Interferon Interferon Interferon Interferon
56 years old. The amount of 2019-nCoV detected in patients’ receptor of SARS-CoV (Xu et al., 2020), which is a critical
respiratory tracts and measured conversely in Ct value, as enzyme in the renin-angiotensin system (RAS) (Huang et al.,
well as the lung injury Murray score and PaO2/FiO2 ratio, 2014; Zou et al., 2014). RAS plays important roles in
may very well predict the disease severity (Figure 5). Among maintaining blood pressure homeostasis (Forrester et al.,
the biochemical indexes, the AUC of ROC for the infection 2018), and salt and fluid balance (Lin et al., 2017). ACE and
and tissue damage indicators, ALB, CRP, and LDH were 1, ACE2 play different roles in RAS; ACE generates Angio-
0.938, and 0.844, respectively, and may also be potential tensin II, whereas ACE2 is a negative regulator of the sys-
predictors of disease severity. The AUCs for lymphocyte tem, decreasing Angiotensin II (Crackower et al. 2002). The
count and the percentage of lymphocytes and neutrophils abnormal increase of Angiotensin II was reported mostly
were 1, 0.844, and 0.812, respectively, and thus may also associated with hypertension and heart failures (Packer and
predict disease severity. McMurray, 2017), and sometimes also lung and renal dys-
A recent article studied the 2019-nCoV genome sequence functions (Fröhlich et al., 2016; Kuba et al., 2005; Zou et al.,
and predicted that the new coronavirus shared the ACE2 2014; Damman et al., 2018; Imai et al., 2005; Rai et al.,
368 Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3
Figure 2 (Color online) Computed tomographic (CT) scans and chest radiographs of case 2. (A) CT scans and (B) chest radiographs of case 2 taken at
indicated date are shown. d.a.o, days after illness onset.
a)
Table 2 Clinical characteristics and laboratory results of subjects hospitalized with 2019-nCoV infection
Normal range Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 Case 10 Case 11 Case 12
PaO2/FiO2 400–500 131 96 159 65 256 438 469 561 420 126 249 386
9 –1
WBC (×10 L ) 3.5–9.5 4.31 5.24 3.85 6.79 6.71 13.55 6.72 4.62 4.94 5.89 4.99 3.98
LYM (%) 20–50 20.4 23.1 21.6 3.8 11.5 17.5 56.4 34.4 29.4 7.1 19.8 20.9
9 –1
LYM (×10 L ) 1.10–3.20 0.88 1.21 0.83 0.26 0.77 2.37 3.79 1.59 1.45 0.42 NA 0.83
NEU (%) 40–75 72.6 67.4 58.7 93 80.9 77.4 33.7 56.8 64.3 90.9 74.8 75.3
9 –1
NEU (×10 L ) 1.8–6.3 3.13 3.53 2.26 6.31 5.43 10.49 2.26 2.62 3.18 5.35 3.73 3
9 –1
PLT (×10 L ) 100–300 161 118 121 119 215 250 196 236 184 118 99 152
–1
AST (U L ) 0–45 26.7 33.6 26 107 26.2 29.3 34.7 28.9 37.7 52 42.1 36.1
–1
ALT (U L ) 0–45 26.6 26.5 26 62 45.3 30 32.8 22.4 39.5 15.7 29 23.6
–1
TB (µmol L ) 3.0–22 10.8 9.5 9.1 6.2 11.6 12 8.5 7.8 7.8 8.4 9.6 5.9
–1
ALB (g L ) 40.0–55.0 36.8 39.5 41.6 35.1 38.3 48.9 46.4 43.4 46.2 34.6 42.6 38.4
–1
CRE (µmol L ) 58–110 46.5 81.9 104 220 44.1 79.7 53 95.4 82.5 54.1 122 43.6
–1
BUN (mmol L ) 3.2–7.1 2.87 5.37 5.51 9.81 4.8 6.65 7.65 4.21 3.71 4.48 6.89 3.12
–1
CK (U L ) 50–310 46 118 97 876 NA 111 70 NA NA NA NA NA
–1
MYO (ng mL ) 0–110 25.2 38.66 50.1 390.97 32.7 35 18.7 20.5 27 40.1 111.9 23.7
–1
Ctnl (µg mL ) 0–0.1 0.012 0.012 0.012 11.37 0.012 0.012 0.012 0.012 0.012 0.014 0.012 0.012
–1
BNP (pmol L ) 0–23.1 4.32 5.7 3.78 161.99 NA NA NA NA NA NA NA NA
–1
CK-MB (ng mL ) 0–2.37 0.24 0.48 <0.22 20.53 <0.22 0.25 0.26 <0.22 <0.22 0.23 0.97 <0.22
–1
LDH (U L ) 114.0–240.0 662 593 169 720 696 491 475 558 476 1266 510 648
–1
CRP (mg L ) <10 52.6 38.6 52.95 89.94 53.6 5.8 5 35.6 13 33.2 85 28.4
–1
PCT (ng mL ) 0–0.5 0.048 0.04 0.095 9.18 0.031 <0.020 <0.020 0.029 <0.020 0.077 0.218 0.033
–1
CD4 (count μL ) 34–52 47.3 45.8 41.2 18.7 30.9 NA NA NA 50.2 34.9 50.7 43
–1
CD8 (count μL ) 21–39 16.7 16.5 11.6 10.9 23 NA NA NA 24.9 14.3 17 17.4
CD4/CD8 0.9–3.6 2.83 2.78 3.56 1.72 1.34 NA NA NA 2.02 2.45 2.98 2.47
a) NA, not available.
Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3 369
Figure 3 The Ct value of virus are highly correlated with clinical and laboratory manifestations in 2019-nCoV-infected patients. The Ct value of virus is
highly correlated with (A) PaO2/FiO2 ratio, Murray score and (B) CRP, ALB, LYM (%), LYM, NEU in 2019-nCoV-infected patients. The Ct value was
detected available in 10 patients with 2019-nCoV infection. PaO2/FiO2 ratio, Murray score, ALB, LYM (%), LYM, NEU, CRP, and LDH were detected from
12 2019-nCoV-infected patients. Spearman rank correlation analysis (r) and P values are provided in each graph.
2017; Torres et al., 2014). We measured the plasma level of infections. All patients were admitted to the Shenzhen Third
Angiotensin II from 2019-nCoV infected patients and heal- People’s Hospital, Shenzhen, China. All patients were either
thy individuals, the plasma levels of Angiotensin II from living in or traveling to Wuhan from late December of 2019
2019-nCoV infected patients were significantly higher than to early January of 2020, except case 5 who stayed in
that of healthy individuals (Figure 6A). Moreover, the level Shenzhen during the time period. Two family clusters were
of Angiotensin II in 2019-nCoV patients was strongly as- identified, and case 5 was in one of the family clusters with
sociated with viral load and lung injury (Figure 6B and C), cases 1, 2, 6, and 7. This secondary infection of case 5 is one
suggesting that the imbalanced renin-angiotensin system in evidence of possible person-to-person spread of 2019-nCoV.
patients was caused by 2019-nCoV and drugs of angiotensin- Cases 1, 2, 6, and 7 might have been simultaneously infected
converting enzyme inhibitor (ACEI) and angiotensin re- in Wuhan, probably by a super-spreader contacting them in
ceptor blocker (ARB) balancing RAS may be used re- the hotel or home of their relatives, as five of their relatives in
purposing on 2019-nCoV infected patients. Wuhan developed similar symptoms (Chan et al., 2020).
Since case 5 had disease onset 4 days after family members
returning from Wuhan, the latency of 2019-nCoV might be
DISCUSSION as short as 1–4 days while the latency of most other patients
was from 7 to 13 days (Figure 1). Two out of the 12 patients
We report 12 cases with laboratory confirmed 2019-nCoV had no diagnosis of fever, including case 7 who had a clinical
370 Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3
Figure 4 The Murray score is highly correlated with laboratory manifestations in 2019-nCoV-infected patients. The Murray score is highly correlated with
ALB, LYM, LDH, LYM (%), NEU (%), and CRP. Murray score, ALB, LYM, LDH, LYM (%), NEU (%), and CRP were detected from 12 2019-nCoV-
infected patients. Spearman rank correlation analysis (r) and P values are provided in each graph.
image check when accompanying family members to the with the Murray scores in patients with 2019-nCoV (Figure
hospital (Table 1). The risk of virus spread increased with 4). The Murray score was originally developed to assess the
non-fever patients, indicating that it is important to establish severity of acute lung injury in ARDS (Murray et al., 1988),
epidemiological history during clinical reception of the pa- and higher scores indicate greater severity in ARDS patients.
tients. This is consistent with previous studies showing that hy-
–1
All samples from the respiratory tract, including throat poalbuminemia, lymphopenia, and CRP ≥4 mg dL were
swabs and BALF, were collected from 10 patients. Com- the predictive factors for pneumonia progression to re-
paring the laboratory tests of these samples, the results of spiratory failure in MERS-CoV infected patients and ele-
throat swabs and BALF collected at the same time from case vated lactate dehydrogenase was found with severe acute
1, 3, and 4 were not consistent (Table S1 in Supporting In- respiratory syndrome (SARS-CoV) infection on hospital
formation), i.e., positive in BALF and negative in throat admission (Ko et al., 2016; Liu et al., 2004; Leem et al.,
swabs, indicating that BALF was a more reliable sample for 2018). Therefore, the combinations of the hypoalbuminemia,
the 2019-nCoV test. It is worth noting that the laboratory test lymphopenia, and high concentrations of CRP and LDH in
of BALF from case 8 was negative, but positive with throat 2019-nCoV infected patients upon hospital admission may
swabs. Case 8 was discharged from our hospital after one predict more severe acute lung injury.
week. Further studies are necessary to elucidate whether the We discovered the markedly increased level of Angio-
foundation of disease was related to the location of the virus tensin II in the plasma samples from 2019-nCoV infected
in the respiratory tract. patients. Our previous mice study has demonstrated that
We found that the viral load was crucial in determining the SARS-CoV could bind to its receptor ACE2, down-reg-
disease severity, especially strongly correlated with lung ulating its expressions, resulting in increased Angiotensin II
injury Murray score (Figure 3A). Notably, the viral load from level in mouse blood samples, signaling through angiotensin
case 4 was very high when fulminant myocarditis also oc- II receptor 1, and induced acute lung injury (Huang et al.,
curred (Table 2 and Figure 3). This high viral load lasted for 2014; Imai et al., 2005; Zou et al., 2014). We have also
one week, indicating that the early detection of high viral reported that avian influenza A virus H5N1 infected mice
load may be associated with a high risk of fulminant myo- exhibited the acute lung injury through dysregulating RAS,
carditis. and markedly elevation of Angiotensin II level in H7N9
Our study provides a list of potential predictors for disease infected patients was associated with the disease severity and
severity. For example, our study demonstrated that ALB and outcomes (Guo et al., 2015; Huang et al., 2014). In addition,
LYM counts were negatively correlated with the Murray a retrospective cohort study in Texas, USA with hospitalized
scores, while CRP and LDH levels were positively correlated pneumonia patients reported that prior and inpatients use of
Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3 371
Figure 5 (Color online) Receiver operating characteristic (ROC) curve of clinical and biochemical indicators of 2019-nCoV-infected patients. (A) ROC
curve of the age, Murray score, Ct value of 2019-nCoV, PaO2/FiO2 ratio and (B) ROC curve of the ALB, LYM, CRP, LYM (%), LDH and NEU (%) were
calculated between four mild 2019-nCov-infected patients and eight severe 2019-nCov-infected patients. Detailed information is shown in Tables 1 and 2.
Figure 6 (Color online) Plasma angiotensin II levels are increased in 2019-nCoV-infected patients and correlated with viral Ct value and PaO2/FiO2 ratio.
(A) Box plot of angiotensin II levels in plasma of healthy controls (n=8) and 2019-nCov-infected patients (n=12). ***, P<0.001 (Mann-Whiney U test). The
correlation analysis between plasma angiotensin II levels and (B) viral Ct value, or (C) PaO2/FiO2 ratio of patients with 2019-nCoV infection. The viral titers
were detected available in 10 patients with 2019-nCoV infection. The PaO2/FiO2 ratio was detected from 12 2019-nCoV-infected patients. Spearman rank
correlation analysis (r) and P values are provided in each graph.
ACE inhibitor and ARB were associated with the decreased demonstrated that ARB drugs, especially losartan, could
mortality (Mortensen et al., 2012). Our previous studies effectively ameliorate mice acute lung injury induced by
372 Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3
(JCYJ20180504165549581 and JCYJ20170413141236903), China Post- S.M., Lau, E.H.Y., Wong, J.Y., et al. (2020). Early transmission
doctoral Science Foundation (2019T120147). dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.
N Engl J Med, https://doi.org/10.1056/NEJMoa2001316.
References Lin, Y.C., Lin, J.W., Wu, M.S., Chen, K.C., Peng, C.C., and Kang, Y.N.
(2017). Effects of calcium channel blockers comparing to angiotensin-
Bi, Y., Tan, S., Yang, Y., Wong, G., Zhao, M., Zhang, Q., Wang, Q., Zhao, converting enzyme inhibitors and angiotensin receptor blockers in
X., Li, L., Yuan, J., et al. (2019). Clinical and immunological patients with hypertension and chronic kidney disease stage 3 to 5 and
characteristics of human infections with H5N6 avian influenza virus. dialysis: A systematic review and meta-analysis. PLoS ONE 12,
Clin Infect Dis 68, 1100–1109. e0188975.
Chan, J.F.W., Yuan, S., Kok, K.H., To, K.K.W., Chu, H., Yang, J., Xing, F., Liu, C.L., Lu, Y.T., Peng, M.J., Chen, P.J., Lin, R.L., Wu, C.L., and Kuo, H.
Liu, J., Yip, C.C.Y., Poon, R.W.S., et al. (2020). A familial cluster of T. (2004). Clinical and laboratory features of severe acute respiratory
pneumonia associated with the 2019 novel coronavirus indicating syndrome vis-a-vis onset of fever. Chest 126, 509–517.
person-to-person transmission: a study of a family cluster. Lancet, Mortensen, E.M., Nakashima, B., Cornell, J., Copeland, L.A., Pugh, M.J.,
https://doi.org/10.1016/S0140-6736(20)30154-9. Anzueto, A., Good, C., Restrepo, M.I., Downs, J.R., Frei, C.R., et al.
Crackower, M.A., Sarao, R., Oudit, G.Y., Yagil, C., Kozieradzki, I., Scanga, (2012). Population-based study of statins, angiotensin II receptor
S.E., Oliveira-dos-Santos, A.J., da Costa, J., Zhang, L., Pei, Y., et al. blockers, and angiotensin-converting enzyme inhibitors on pneumonia-
(2002). Angiotensin-converting enzyme 2 is an essential regulator of related outcomes. Clin Infect Dis 55, 1466–1473.
heart function. Nature 417, 822–828. Murray, J.F., Matthay, M.A., Luce, J.M., and Flick, M.R. (1988). An
Damman, K., Gori, M., Claggett, B., Jhund, P.S., Senni, M., Lefkowitz, M. expanded definition of the adult respiratory distress syndrome. Am Rev
P., Prescott, M.F., Shi, V.C., Rouleau, J.L., Swedberg, K., et al. (2018). Respir Dis 138, 720–723.
Renal effects and associated outcomes during angiotensin-neprilysin Niu, P., Zhao, G., Deng, Y., Sun, S., Wang, W., Zhou, Y., and Tan, W.
inhibition in heart failure. JACC-Heart Failure 6, 489–498. (2018). A novel human mAb (MERS-GD27) provides prophylactic and
Forrester, S.J., Booz, G.W., Sigmund, C.D., Coffman, T.M., Kawai, T., postexposure efficacy in MERS-CoV susceptible mice. Sci China Life
Rizzo, V., Scalia, R., and Eguchi, S. (2018). Angiotensin II signal Sci 61, 1280–1282.
transduction: an update on mechanisms of physiology and Packer, M., and McMurray, J.J.V. (2017). Importance of endogenous
pathophysiology. Physiol Rev 98, 1627–1738. compensatory vasoactive peptides in broadening the effects of
Fröhlich, H., Nelges, C., Täger, T., Schwenger, V., Cebola, R., Schnorbach, inhibitors of the renin-angiotensin system for the treatment of heart
J., Goode, K.M., Kazmi, S., Katus, H.A., Cleland, J.G.F., et al. (2016). failure. Lancet 389, 1831–1840.
Long-term changes of renal function in relation to ace inhibitor/ Rai, A.K., Sanjukta, S., and Jeyaram, K. (2017). Production of angiotensin
angiotensin receptor blocker dosing in patients with heart failure and I converting enzyme inhibitory (ACE-I) peptides during milk
chronic kidney disease. Am Heart J 178, 28–36. fermentation and their role in reducing hypertension. Crit Rev Food
Guo, J., Huang, F., Liu, J., Chen, Y., Wang, W., Cao, B., Zou, Z., Liu, S., Sci Nutrit 57, 2789–2800.
Pan, J., Bao, C., et al. (2015). The serum profile of hypercytokinemia Tan, W., Zhao, X., Ma, X., Wang, W., Niu, P., Xu, W., Gao, G.F., and Wu,
factors identified in H7N9-infected patients can predict fatal outcomes. G. (2020). A novel coronavirus genome identified in a cluster of
Sci Rep 5, 10942. pneumonia cases—Wuhan, China 2019–2020. China CDC Weekly 2,
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., 61–62.
Xu, J., Gu, X., et al. (2020). Clinical features of patients infected with Torres, V.E., Abebe, K.Z., Chapman, A.B., Schrier, R.W., Braun, W.E.,
2019 novel coronavirus in Wuhan, China. Lancet, https://doi.org/ Steinman, T.I., Winklhofer, F.T., Brosnahan, G., Czarnecki, P.G.,
10.1016/S0140-6736(20)30183-5. Hogan, M.C., et al. (2014). Angiotensin blockade in late autosomal
Huang, F., Guo, J., Zou, Z., Liu, J., Cao, B., Zhang, S., Li, H., Wang, W., dominant polycystic kidney disease. N Engl J Med 371, 2267–2276.
Sheng, M., Liu, S., et al. (2014). Angiotensin II plasma levels are linked Vincent, J.L., Dubois, M.J., Navickis, R.J., and Wilkes, M.M. (2003).
to disease severity and predict fatal outcomes in H7N9-infected Hypoalbuminemia in acute illness: is there a rationale for intervention?
patients. Nat Commun 5, 3595. Ann Surgery 237, 319–334.
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., and Hao,
Wada, T., Leong-Poi, H., et al. (2005). Angiotensin-converting enzyme P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan
2 protects from severe acute lung failure. Nature 11, 112–116. outbreak and modeling of its spike protein for risk of human
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S., Liu, J., Luo, W., Chen, T., transmission. Sci China Life Sci, https://doi.org/10.1007/s11427-020-
Qin, Q., and Deng, P. (2005). Characterization of cytokine/chemokine 1637-5.
profiles of severe acute respiratory syndrome. Am J Respir Crit Care Yan, Y.W., Liu, Q., Li, N., Du, J.C., Li, X., Li, C., Jin, N.Y., and Jiang, C.Y.
Med 171, 850–857. (2015). Angiotensin II receptor blocker as a novel therapy in acute lung
Ko, J.H., Park, G.E., Lee, J.Y., Lee, J.Y., Cho, S.Y., Ha, Y.E., Kang, C.I., injury induced by avian influenza A H5N1 virus infection in mouse. Sci
Kang, J.M., Kim, Y.J., Huh, H.J., et al. (2016). Predictive factors for China Life Sci 58, 208–211.
pneumonia development and progression to respiratory failure in Yang, Y., Wong, G., Yang, L., Tan, S., Li, J., Bai, B., Xu, Z., Li, H., Xu, W.,
MERS-CoV infected patients. J Infection 73, 468–475. Zhao, X., et al. (2019). Comparison between human infections caused
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., by highly and low pathogenic H7N9 avian influenza viruses in Wave
Zhang, Y., Deng, W., et al. (2005). A crucial role of angiotensin Five: Clinical and virological findings. J Infection 78, 241–248.
converting enzyme 2 (ACE2) in SARS coronavirus–induced lung Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang,
injury. Nat Med 11, 875–879. B., Shi, W., Lu, R., et al. (2020). A Novel Coronavirus from Patients
Leem, A.Y., Park, B., Kim, Y.S., Jung, J.Y., and Won, S. (2018). Incidence with Pneumonia in China, 2019. N Engl J Med, doi: 10.1056/NEJ-
and risk of chronic obstructive pulmonary disease in a Korean Moa2001017.
community-based cohort. Int J Chron Obstruct Pulmon Dis 13, 509– Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q.,
517. Zhao, Y., et al. (2014). Angiotensin-converting enzyme 2 protects from
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. lethal avian influenza A H5N1 infections. Nat Commun 5, 3594.
374 Liu, Y., et al. Sci China Life Sci March (2020) Vol.63 No.3
SUPPORTING INFORMATION
Figure S1 Computed tomographic (CT) scans of human cases with 2019-nCoV. CT scans of cases 1 and 3–12 taken at indicated date are
shown.
Figure S2 Assessment of the myocardial function in case 4. A and B, The ultrasonic cardiogram results. C, The left ventricular ejection
fraction (LVEF) and the left ventricular diameter (LV) at the indicated date.
Figure S3 The correlation between APACHE II scores and viral Ct value in 2019-nCoV-infected patients. The viral titers were detected
available in 10 patients with 2019-nCoV infection. APACHE II scores were detected from 12 2019-nCoV-infected patients. Spearman rank
correlation analysis (r) and P values are provided in the graph.
Table S1 The Ct values of different sample types from the same case determined by qRT-PCR
The supporting information is available online at http://life.scichina.com and https://link.springer.com. The supporting
materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content
remains entirely with the authors.